Corticosteroids for treating mild COVID-19: opening the floodgates of therapeutic misadventure.
作者信息
Ray A, Goel A, Wig N
机构信息
Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansarinagar, New Delhi 110029, India.
出版信息
QJM. 2021 Nov 5;114(8):541-542. doi: 10.1093/qjmed/hcab138.
Abstract
摘要
相似文献
1
Corticosteroids for treating mild COVID-19: opening the floodgates of therapeutic misadventure.
QJM. 2021 Nov 5;114(8):541-542. doi: 10.1093/qjmed/hcab138.
2
Corticosteroids for mild COVID-19 treatment: opening the floodgates of therapeutic benefits.
QJM. 2022 Oct 25;115(10):701. doi: 10.1093/qjmed/hcab312.
3
Response to: Corticosteroids for mild COVID-19 treatment: opening the floodgates of therapeutic benefits.
QJM. 2022 Oct 25;115(10):702-703. doi: 10.1093/qjmed/hcab313.
4
Corticosteroids in patients with COVID-19: use and misuse.
Minerva Anestesiol. 2021 Sep;87(9):1042-1048. doi: 10.23736/S0375-9393.21.15625-1. Epub 2021 Jun 8.
5
Systemic corticosteroids for COVID-19.
Acad Emerg Med. 2022 Feb;29(2):252-254. doi: 10.1111/acem.14432. Epub 2022 Jan 4.
6
Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e270-e271. doi: 10.3928/19382359-20210701-01. Epub 2021 Jul 1.
7
Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
Pediatr Ann. 2021 Jul;50(7):e271. doi: 10.3928/19382359-20210520-01. Epub 2021 Jul 1.
8
Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial.
Eur Respir J. 2021 Jul 29;58(1). doi: 10.1183/13993003.00130-2021. Print 2021 Jul.
9
Role of corticosteroids in the treatment of COVID-19 infection.
Minerva Anestesiol. 2020 Nov;86(11):1249-1250. doi: 10.23736/S0375-9393.20.14864-8. Epub 2020 Jun 12.
10
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).
Obstet Gynecol. 2021 Feb 1;137(2):378-379. doi: 10.1097/AOG.0000000000004272.
引用本文的文献
1
Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
Indian J Ophthalmol. 2024 Oct 1;72(10):1519-1523. doi: 10.4103/IJO.IJO_2799_23. Epub 2024 Sep 27.
2
A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India.
J Family Med Prim Care. 2024 Jul;13(7):2653-2662. doi: 10.4103/jfmpc.jfmpc_1734_23. Epub 2024 Jun 28.
3
Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study.
Virol J. 2024 Mar 21;21(1):71. doi: 10.1186/s12985-024-02325-x.
4
COVID-19-Associated Rhino-Orbital Mucormycosis in a Tertiary Health Care Center in Odisha, India.
Cureus. 2023 Aug 20;15(8):e43811. doi: 10.7759/cureus.43811. eCollection 2023 Aug.
5
COVID-19 and chronic diabetes: the perfect storm for reactivation tuberculosis?: a case series.
J Med Case Rep. 2021 Dec 16;15(1):621. doi: 10.1186/s13256-021-03193-7.
6
Response to: Corticosteroids for mild COVID-19 treatment: opening the floodgates of therapeutic benefits.
QJM. 2022 Oct 25;115(10):702-703. doi: 10.1093/qjmed/hcab313.
7
COVID-19-associated subacute invasive pulmonary aspergillosis.
Mycoses. 2022 Jan;65(1):57-64. doi: 10.1111/myc.13369. Epub 2021 Sep 29.
8
COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients.
QJM. 2021 Nov 5;114(7):464-470. doi: 10.1093/qjmed/hcab190.
Zotero 插件